These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
|||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
|
|
|
|
|
|||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
x
|
Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | o | Smaller reporting company |
|
|||||||||||||||||
| Emerging growth company |
|
|||||||||||||||||||
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | |||||||||||||||||||
|
|
Page | |||||||
| PART I | ||||||||
| Item 1. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| PART II | ||||||||
| Item 1. | ||||||||
| Item 1A. | ||||||||
| Item 2. | ||||||||
| Item 6. | ||||||||
| (In thousands, except stock data) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Receivables, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Costs and earnings on contracts in excess of billings |
|
|
||||||||||||
| Other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||
| Operating lease right-of-use assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets |
|
|
||||||||||||
| Other non-current assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||
| Current liabilities | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued payroll and related benefits |
|
|
||||||||||||
| Billings in excess of costs and earnings on uncompleted contracts |
|
|
||||||||||||
| Operating lease liabilities |
|
|
||||||||||||
| Current portion long-term debt |
|
|
||||||||||||
| Other current liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term debt |
|
|
||||||||||||
| Non-current operating lease liabilities |
|
|
||||||||||||
| Non-current self-insurance reserves |
|
|
||||||||||||
| Other non-current liabilities |
|
|
||||||||||||
| Commitments and contingent liabilities (Note 8) | ||||||||||||||
| Shareholders’ equity | ||||||||||||||
|
Common stock of $
|
|
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands, except per share data) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Operating income |
|
|
|
|
||||||||||||||||||||||
| Interest expense, net |
|
|
|
|
||||||||||||||||||||||
| Other expense, net |
|
|
|
|
||||||||||||||||||||||
| Earnings before income taxes |
|
|
|
|
||||||||||||||||||||||
| Income tax expense |
|
|
|
|
||||||||||||||||||||||
| Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Earnings per share - basic | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Earnings per share - diluted | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Weighted average basic shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Weighted average diluted shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other comprehensive (losses) earnings: | ||||||||||||||||||||||||||
|
Unrealized loss on marketable securities, net of $(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Unrealized gain (loss) on derivative instruments, net of $
|
|
(
|
(
|
(
|
||||||||||||||||||||||
| Foreign currency translation adjustments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Other comprehensive losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total comprehensive earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Nine Months Ended | ||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net earnings | $ |
|
$ |
|
||||||||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Share-based compensation |
|
|
||||||||||||
| Deferred income taxes |
|
(
|
||||||||||||
| Asset impairment |
|
|
||||||||||||
| Gain on disposal of assets |
(
|
(
|
||||||||||||
| Proceeds from New Markets Tax Credit transaction, net of deferred costs |
|
|
||||||||||||
| Settlement of New Markets Tax Credit transaction |
(
|
|
||||||||||||
| Noncash lease expense |
|
|
||||||||||||
| Other, net |
|
|
||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Receivables |
(
|
|
||||||||||||
| Inventories |
(
|
(
|
||||||||||||
| Costs and earnings on contracts in excess of billings |
(
|
|
||||||||||||
| Accounts payable and accrued expenses |
(
|
|
||||||||||||
| Billings in excess of costs and earnings on uncompleted contracts |
|
(
|
||||||||||||
| Refundable and accrued income taxes |
(
|
|
||||||||||||
| Operating lease liability |
(
|
(
|
||||||||||||
| Other, net |
(
|
(
|
||||||||||||
| Net cash provided by operating activities |
|
|
||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures |
(
|
(
|
||||||||||||
| Proceeds from sales of property, plant and equipment |
|
|
||||||||||||
| Other, net |
|
|
||||||||||||
| Net cash used by investing activities |
(
|
(
|
||||||||||||
| Financing Activities | ||||||||||||||
| Borrowings on line of credit |
|
|
||||||||||||
| Repayment on debt |
(
|
(
|
||||||||||||
| Payments on line of credit |
(
|
|
||||||||||||
| Payments on debt issue costs |
(
|
|
||||||||||||
| Proceeds from exercise of stock options |
|
|
||||||||||||
| Repurchase and retirement of common stock |
(
|
(
|
||||||||||||
| Dividends paid |
(
|
(
|
||||||||||||
| Other, net |
(
|
(
|
||||||||||||
| Net cash used by financing activities |
(
|
(
|
||||||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash |
(
|
|
||||||||||||
| Effect of exchange rates on cash |
|
|
||||||||||||
| Cash, cash equivalents and restricted cash at beginning of year |
|
|
||||||||||||
| Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
||||||||||
| Noncash Activity | ||||||||||||||
| Capital expenditures in accounts payable | $ |
|
$ |
|
||||||||||
| (In thousands) | Common Shares Outstanding | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) Income | Total Shareholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at February 26, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on marketable securities, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on derivative instruments, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
|
|
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share repurchases |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at May 28, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on marketable securities, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on derivative instruments, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
(
|
(
|
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options |
|
|
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at August 27, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on marketable securities, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gain on derivative instruments, net of $
|
— | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
|
|
|
(
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at November 26, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| (In thousands) | Common Shares Outstanding | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) Income | Total Shareholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||
| Balance at February 27, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gain on marketable securities, net of $
|
— | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gain on derivative instruments, net of $
|
— | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
|
|
(
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options |
|
|
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share repurchases |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at May 29, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized gain on marketable securities, net of $
|
— | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on derivative instruments, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
|
|
— | — | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share repurchases |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at August 28, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on marketable securities, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Unrealized loss on derivative instruments, net of $
|
— | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock, net of cancellations |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||||
| Share repurchases |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Other share retirements |
(
|
(
|
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Cash dividends | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance at November 27, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Recognized at shipment | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Recognized over time |
|
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Trade accounts | $ |
|
$ |
|
||||||||||
| Construction contracts |
|
|
||||||||||||
| Contract retainage |
|
|
||||||||||||
| Total receivables |
|
|
||||||||||||
| Less: allowance for credit losses |
|
|
||||||||||||
| Receivables, net | $ |
|
$ |
|
||||||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Beginning balance | $ |
|
$ |
|
||||||||||
| Additions charged to costs and expenses |
|
|
||||||||||||
| Deductions from allowance, net of recoveries |
(
|
(
|
||||||||||||
|
Other changes
(1)
|
(
|
(
|
||||||||||||
| Ending balance | $ |
|
$ |
|
||||||||||
|
(1)
Result of foreign currency effects
|
||||||||||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Contract assets | $ |
|
$ |
|
||||||||||
| Contract liabilities |
|
|
||||||||||||
| Other contract-related disclosures | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Revenue recognized related to contract liabilities from prior year-end | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Revenue recognized related to prior satisfaction of performance obligations |
|
|
|
|
||||||||||||||||||||||
| (In thousands) | November 26, 2022 | |||||||
|
Within
|
$ |
|
||||||
|
Within
|
|
|||||||
|
Beyond
|
|
|||||||
| Total | $ |
|
||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Raw materials | $ |
|
$ |
|
||||||||||
| Work-in-process |
|
|
||||||||||||
| Finished goods |
|
|
||||||||||||
| Total inventories | $ |
|
$ |
|
||||||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Warranties | $ |
|
$ |
|
||||||||||
| Income and other taxes |
|
|
||||||||||||
| Accrued self-insurance reserves |
|
|
||||||||||||
| Accrued freight |
|
|
||||||||||||
| Deferred revenue |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Total other current liabilities | $ |
|
$ |
|
||||||||||
| (In thousands) | November 26, 2022 | February 26, 2022 | ||||||||||||
| Deferred benefit from New Markets Tax Credit transactions | $ |
|
$ |
|
||||||||||
| Retirement plan obligations |
|
|
||||||||||||
| Deferred compensation plan |
|
|
||||||||||||
| Deferred tax liabilities |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Total other non-current liabilities | $ |
|
$ |
|
||||||||||
| (In thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses |
Estimated
Fair Value |
||||||||||||||||||||||
| November 26, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| February 26, 2022 |
|
|
|
|
||||||||||||||||||||||
| (In thousands) | Amortized Cost | Estimated Fair Value | ||||||||||||
| Due within one year | $ |
|
$ |
|
||||||||||
| Due after one year through five years |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| (In thousands) |
Quoted Prices in
Active Markets (Level 1) |
Other Observable Inputs (Level 2) | Total Fair Value | |||||||||||||||||
| November 26, 2022 | ||||||||||||||||||||
| Assets: | ||||||||||||||||||||
| Money market funds | $ |
|
$ | — | $ |
|
||||||||||||||
| Municipal and corporate bonds | — |
|
|
|||||||||||||||||
| Cash surrender value of life insurance | — |
|
|
|||||||||||||||||
| Interest rate swap contract | — |
|
|
|||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deferred compensation | — |
|
|
|||||||||||||||||
| Foreign currency forward/option contract | — |
|
|
|||||||||||||||||
| Aluminum hedging contract | — |
|
|
|||||||||||||||||
| February 26, 2022 | ||||||||||||||||||||
| Assets: | ||||||||||||||||||||
| Money market funds | $ |
|
$ | — | $ |
|
||||||||||||||
| Municipal and corporate bonds | — |
|
|
|||||||||||||||||
| Cash surrender value of life insurance | — |
|
|
|||||||||||||||||
| Aluminum hedging contract | — |
|
|
|||||||||||||||||
| Interest rate swap contract | — |
|
|
|||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deferred compensation | — |
|
|
|||||||||||||||||
| Foreign currency forward/option contract | — |
|
|
|||||||||||||||||
| (In thousands) | Architectural Framing Systems | Architectural Services | Architectural Glass |
Large-Scale
Optical |
Total | |||||||||||||||||||||||||||
| Balance at February 27, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Foreign currency translation |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Balance at February 26, 2022 |
|
|
|
|
|
|||||||||||||||||||||||||||
|
Reallocation among reporting units
(1)
|
(
|
|
|
|
|
|||||||||||||||||||||||||||
| Foreign currency translation |
(
|
(
|
|
|
(
|
|||||||||||||||||||||||||||
| Balance at November 26, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
(1)
Represents the reallocation of goodwill as a result of transitioning Sotawall from the Architectural Framing Systems segment to the Architectural Services segment as of the start of the first quarter of fiscal 2023.
|
||||||||||||||||||||||||||||||||
| (In thousands) |
Gross
Carrying Amount |
Accumulated
Amortization |
Impairment Expense |
Foreign
Currency Translation |
Net | |||||||||||||||||||||||||||
| November 26, 2022 | ||||||||||||||||||||||||||||||||
| Definite-lived intangible assets: | ||||||||||||||||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||
| Other intangibles |
|
(
|
|
(
|
|
|||||||||||||||||||||||||||
| Total |
|
(
|
|
(
|
|
|||||||||||||||||||||||||||
| Indefinite-lived intangible assets: | ||||||||||||||||||||||||||||||||
| Trademarks |
|
— |
|
(
|
|
|||||||||||||||||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||
| February 26, 2022 | ||||||||||||||||||||||||||||||||
| Definite-lived intangible assets: | ||||||||||||||||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||
| Other intangibles |
|
(
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Total |
|
(
|
(
|
|
|
|||||||||||||||||||||||||||
| Indefinite-lived intangible assets: | ||||||||||||||||||||||||||||||||
| Trademarks |
|
— |
(
|
|
|
|||||||||||||||||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||
| (In thousands) | Remainder of 2023 | 2024 | 2025 | 2026 | 2027 | |||||||||||||||||||||||||||
| Estimated amortization expense | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Operating lease cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Short-term lease cost |
|
|
|
|
||||||||||||||||||||||
| Variable lease cost |
|
|
|
|
||||||||||||||||||||||
| Total lease cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Nine Months Ended | ||||||||||||||
| (In thousands except weighted-average data) | November 26, 2022 | November 27, 2021 | ||||||||||||
| Cash paid for amounts included in the measurement of operating lease liabilities | $ |
|
$ |
|
||||||||||
| Lease assets obtained in exchange for new operating lease liabilities | $ |
|
$ |
|
||||||||||
| Weighted-average remaining lease term - operating leases |
|
|
||||||||||||
| Weighted-average discount rate - operating leases |
|
% |
|
% | ||||||||||
| (In thousands) | November 26, 2022 | |||||||
| Remainder of Fiscal 2023 | $ |
|
||||||
| Fiscal 2024 |
|
|||||||
| Fiscal 2025 |
|
|||||||
| Fiscal 2026 |
|
|||||||
| Fiscal 2027 |
|
|||||||
| Fiscal 2028 |
|
|||||||
| Thereafter |
|
|||||||
| Total lease payments |
|
|||||||
| Less: Amounts representing interest |
|
|||||||
| Present value of lease liabilities | $ |
|
||||||
| Nine Months Ended | ||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | ||||||||||||
| Balance at beginning of period | $ |
|
$ |
|
||||||||||
| Additional accruals |
|
|
||||||||||||
| Claims paid |
(
|
(
|
||||||||||||
| Balance at end of period | $ |
|
$ |
|
||||||||||
| Inception date | Termination date | Deferred Benefit | Deferred costs | Net benefit | ||||||||||||||||||||||
| June 2016 | June 2023 | $ |
|
$ |
|
$ |
|
|||||||||||||||||||
| September 2018 | September 2025 |
|
|
|
||||||||||||||||||||||
|
May 2022
(1)
|
August 2025 |
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Stock Options | Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value | ||||||||||||||||||||||
| Outstanding at beginning of year |
|
$ |
|
|||||||||||||||||||||||
| Awards exercised |
(
|
|
||||||||||||||||||||||||
| Awards canceled/expired |
(
|
|
||||||||||||||||||||||||
| Outstanding and expected to vest at November 26, 2022 |
|
$ |
|
|
$ |
|
||||||||||||||||||||
| Nonvested shares and units | Number of Shares and Units | Weighted Average Grant Date Fair Value | ||||||||||||
|
Nonvested at February 26, 2022
(1)
|
|
$ |
|
|||||||||||
|
Granted
(2)
|
|
|
||||||||||||
| Vested |
(
|
|
||||||||||||
|
Canceled
(3)
|
(
|
|
||||||||||||
|
Nonvested at November 26, 2022
(4)
|
|
$ |
|
|||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
|
Basic earnings per share – weighted average common shares outstanding
|
|
|
|
|
||||||||||||||||||||||
|
Weighted average effect of nonvested share grants and assumed exercise of stock options
|
|
|
|
|
||||||||||||||||||||||
|
Diluted earnings per share – weighted average common shares and potential common shares outstanding
|
|
|
|
|
||||||||||||||||||||||
|
Stock awards excluded from the calculation of earnings per share because the effect was anti-dilutive (award price greater than average market price of the shares)
|
|
|
|
|
||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||||
| Net sales | ||||||||||||||||||||||||||
| Architectural Framing Systems | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Architectural Services |
|
|
|
|
||||||||||||||||||||||
| Architectural Glass |
|
|
|
|
||||||||||||||||||||||
| Large-Scale Optical |
|
|
|
|
||||||||||||||||||||||
| Intersegment eliminations |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Operating income (loss) | ||||||||||||||||||||||||||
| Architectural Framing Systems | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Architectural Services |
|
|
|
|
||||||||||||||||||||||
| Architectural Glass |
|
(
|
|
(
|
||||||||||||||||||||||
| Large-Scale Optical |
|
|
|
|
||||||||||||||||||||||
| Corporate and other |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Operating income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| (In thousands) | Architectural Framing | Architectural Glass | Corporate & Other | Total | ||||||||||||||||||||||
| Balance at February 27, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Restructuring expense |
|
|
|
|
||||||||||||||||||||||
| Payments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Other adjustments |
(
|
|
|
(
|
||||||||||||||||||||||
| Balance at February 26, 2022 |
|
|
|
|
||||||||||||||||||||||
| Restructuring expense |
|
|
|
|
||||||||||||||||||||||
| Payments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Other adjustments |
(
|
(
|
|
(
|
||||||||||||||||||||||
| Balance at November 26, 2022 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| November 26, 2022 | November 27, 2021 | November 26, 2022 | November 27, 2021 | ||||||||||||||||||||
| Net sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| Cost of sales | 76.5 | 80.6 | 76.5 | 81.7 | |||||||||||||||||||
| Gross profit | 23.5 | 19.4 | 23.5 | 18.3 | |||||||||||||||||||
| Selling, general and administrative expenses | 14.1 | 14.1 | 14.3 | 15.2 | |||||||||||||||||||
| Operating income | 9.4 | 5.3 | 9.1 | 3.1 | |||||||||||||||||||
| Interest expense, net | 0.7 | 0.2 | 0.5 | 0.3 | |||||||||||||||||||
| Other expense, net | 0.2 | 0.9 | 0.2 | 0.3 | |||||||||||||||||||
| Earnings before income taxes | 8.6 | 4.2 | 8.4 | 2.5 | |||||||||||||||||||
| Income tax expense | 2.1 | 0.9 | 0.8 | 0.5 | |||||||||||||||||||
| Net earnings | 6.5 | % | 3.3 | % | 7.6 | % | 2.0 | % | |||||||||||||||
| Effective tax rate | 24.8 | % | 21.7 | % | 9.3 | % | 19.6 | % | |||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | % Change | November 26, 2022 | November 27, 2021 | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 165,013 | $ | 141,462 | 16.6 | % | $ | 501,172 | $ | 415,203 | 20.7 | % | ||||||||||||||||||||||||||
| Operating income | 22,089 | 12,085 | 82.8 | % | 66,266 | 28,837 | 129.8 | % | ||||||||||||||||||||||||||||||
| Operating margin | 13.4 | % | 8.5 | % | 13.2 | % | 6.9 | % | ||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | % Change | November 26, 2022 | November 27, 2021 | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 102,031 | $ | 105,404 | (3.2) | % | $ | 312,151 | $ | 292,506 | 6.7 | % | ||||||||||||||||||||||||||
| Operating income | 6,032 | 7,807 | (22.7) | % | 14,449 | 19,172 | (24.6) | % | ||||||||||||||||||||||||||||||
| Operating margin | 5.9 | % | 7.4 | % | 4.6 | % | 6.6 | % | ||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | % Change | November 26, 2022 | November 27, 2021 | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 81,541 | $ | 74,289 | 9.8 | % | $ | 235,158 | $ | 236,693 | (0.6) | % | ||||||||||||||||||||||||||
| Operating income (loss) | 7,461 | (1,277) | 684.3 | % | 19,087 | (16,143) | 218.2 | % | ||||||||||||||||||||||||||||||
| Operating margin | 9.1 | % | (1.7) | % | 8.1 | % | (6.8) | % | ||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | % Change | November 26, 2022 | November 27, 2021 | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 26,660 | $ | 27,351 | (2.5) | % | $ | 76,988 | $ | 75,122 | 2.5 | % | ||||||||||||||||||||||||||
| Operating income | 7,109 | 5,996 | 18.6 | % | 19,598 | 17,326 | 13.1 | % | ||||||||||||||||||||||||||||||
| Operating margin | 26.7 | % | 21.9 | % | 25.5 | % | 23.1 | % | ||||||||||||||||||||||||||||||
| Selected cash flow data | Nine Months Ended | |||||||||||||
| (In thousands) | November 26, 2022 | November 27, 2021 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net cash provided by operating activities | $ | 51,112 | $ | 86,291 | ||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (18,119) | (13,070) | ||||||||||||
| Proceeds from sales of property, plant and equipment | 5,212 | 1,347 | ||||||||||||
| Financing Activities | ||||||||||||||
| Borrowings on line of credit | 430,879 | — | ||||||||||||
| Repayment on debt | (151,000) | (2,000) | ||||||||||||
| Payments on line of credit | (239,000) | — | ||||||||||||
| Repurchase and retirement of common stock | (74,312) | (29,164) | ||||||||||||
| Dividends paid | (14,415) | (15,050) | ||||||||||||
| Period | Total Number of Shares Purchased (a) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b) | Maximum Number of Shares that May Yet Be Purchased under the Plans or Programs (b) | ||||||||||||||||||||||
| August 28, 2022 to September 24, 2022 | 3,351 | $ | 41.16 | — | 1,253,399 | |||||||||||||||||||||
| September 25, 2022 to October 22, 2022 | 1,639 | 38.22 | — | 1,253,399 | ||||||||||||||||||||||
| October 23, 2022 to November 26, 2022 | — | — | — | 1,253,399 | ||||||||||||||||||||||
| Total | 4,990 | $ | 40.57 | — | 1,253,399 | |||||||||||||||||||||
| 101# |
The following materials from Apogee Enterprises, Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 26, 2022, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Balance Sheets as of November 26, 2022 and February 26, 2022, (ii) the Consolidated Results of Operations for the three- and nine-months ended November 26, 2022 and November 27, 2021, (iii) the Consolidated Statements of Comprehensive Earnings for the three- and nine-months ended November 26, 2022 and November 27, 2021, (iv) the Consolidated Statements of Cash Flows for the nine-months ended November 26, 2022 and November 27, 2021, (v) the Consolidated Statements of Shareholders' Equity for the three- and nine-months ended November 26, 2022 and November 27, 2021, and (vi) Notes to Consolidated Financial Statements.
|
||||
| 104# | Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101) | ||||
| Exhibits marked with a (#) sign are filed herewith. | |||||
| APOGEE ENTERPRISES, INC. | |||||||||||
| Date: December 29, 2022 | By: /s/ Ty R. Silberhorn | ||||||||||
|
Ty R. Silberhorn
President and Chief Executive Officer (Principal Executive Officer) |
|||||||||||
| Date: December 29, 2022 | By: /s/ Mark R. Augdahl | ||||||||||
|
Mark R. Augdahl
Interim Chief Financial Officer (Principal Financial and Accounting Officer) |
|||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|